Safety of Metformin in Patients With Chronic Liver Disease

08:00 EDT 6 Apr 2020 | Medscape

The FDA advises against metformin use in hepatic impairment because of the risk of inducing lactic acidosis. Is this warning warranted?
Alimentary Pharmacology & Therapeutics

Original Article: Safety of Metformin in Patients With Chronic Liver Disease

More From BioPortfolio on "Safety of Metformin in Patients With Chronic Liver Disease"